Literature DB >> 19672374

What happens to the patients with muscle-invasive bladder cancer who refuse cystectomy after neoadjuvant chemotherapy?

Ruchir Maheshwari1, Aneesh Srivastava.   

Abstract

Entities:  

Year:  2009        PMID： 19672374      PMCID： PMC2710092     

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


× No keyword cloud information.
  5 in total

Review 1.  Neoadjuvant chemotherapy in patients with invasive bladder cancer.

Authors:  David J Vaughn; S Bruce Malkowicz
Journal:  Urol Clin North Am       Date:  2005-05       Impact factor: 2.241

2.  Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-21       Impact factor: 20.096

3.  Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience.

Authors:  Sisto Perdonà; Riccardo Autorino; Rocco Damiano; Marco De Sio; Brunello Morrica; Luigi Gallo; Giustino Silvestro; Antonio Farella; Sabino De Placido; Giuseppe Di Lorenzo
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

4.  Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

Authors:  P K Schultz; H W Herr; Z F Zhang; D F Bajorin; A Seidman; A Sarkis; W R Fair; D Scherr; G J Bosl; H I Scher
Journal:  J Clin Oncol       Date:  1994-07       Impact factor: 44.544

5.  Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Authors:  Harry W Herr
Journal:  Eur Urol       Date:  2007-12-27       Impact factor: 20.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.